Ancora Pharmaceuticals Inc.
- UEI
- P4NFJGQZLPA3
- CAGE
- 489U6
- Primary NAICS
- 325199 All Other Basic Organic Chemical Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- hamabeadslima.com
- Industry
-
- Consumer Discretionary
- Consumer Durables & Apparel
- Textiles, Apparel & Luxury Goods
- Apparel, Accessories & Luxury Goods
- SIC code
- 51 Wholesale Trade – Nondurable Goods
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Synthesis of glycosaminoglycans | National Cancer Institute (NIH) | $299,248 |
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Evaluation of a synthetic anti-GPI vaccine candidate in severe anemia models of m | National Institutes of Health | $530,977 | |
| Development of an anti-malaria toxin vaccine candidate | National Institutes of Health | $1,186,750 |
Quick answers
Is Ancora Pharmaceuticals Inc. registered in SAM.gov?
Ancora Pharmaceuticals Inc.'s SAM.gov registration expired on December 15, 2015.
What is Ancora Pharmaceuticals Inc.'s most recent federal award?
Ancora Pharmaceuticals Inc.'s most recent federal contract award is Synthesis of glycosaminoglycans (HHSN261201300049C), from National Cancer Institute (NIH), on September 12, 2013.
On GovTribe
See Ancora Pharmaceuticals Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors